Clinical Trials Browser

Phase 2 × OTHER × Gastric / Gastroesophageal Junction Adenocarcinoma × Clear all

NCT07127822 2025-08-17

Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer

Phase 2 Not yet recruiting

GastrointestinalOther solid neoplasm

Gastric / Gastroesophageal Junction Adenocarcinoma